Research led by researchers at UW–Madison will leverage new ways of delivering drug therapies through nanotechnology with advanced genome CRISPR technology to innovate new treatments for two hereditary diseases that cause blindness.
Read the full article at: https://news.wisc.edu/uw-researchers-will-trial-gene-editing-therapy-to-treat-blindness/Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.